As of June 2, 977 cases of STSS have been documented this year, marking a troubling milestone in the country's battle against this deadly disease. The mortality rate of STSS is as high as 30%, respectfully, with 77 fatalities recorded between January and March, surpassing last year’s 941 infections.1
According to the CDC, STSS is a severe infection characterized by rapid progression leading to shock and failure of multiple organs. Diagnosing STSS poses challenges, often resulting in misdiagnosis. Treatment strategies primarily target managing shock and addressing organ failure, typically involving antibiotics, and sometimes necessitating surgical intervention to eliminate the infection's source.2
3 Key Takeaways
- Japan has seen a troubling surge with 977 documented cases of streptococcal toxic shock syndrome (STSS) this year, resulting in 77 fatalities between January and March alone, surpassing last year's total of 941 infections.
- STSS is a severe infection characterized by rapid progression to shock and multiple organ failure, presenting diagnostic challenges that often lead to misdiagnosis.
- Prophylaxis, typically not recommended for those exposed to group A strep infections, may be considered for high-risk individuals or household members of confirmed cases, stressing early detection and treatment amid escalating STSS cases in Japan.
Symptoms and Prevention
There are no vaccines for invasive Group A strep, although vaccines are in development.3
This rare but serious infection occurs when strep A bacteria invade deep tissues and the bloodstream, causing symptoms that initially include fever, muscle pain, and vomiting. As the disease progresses, it can lead to severe complications such as low blood pressure, swelling, and multiple organ failure. Additional symptoms may include swelling and redness of the affected area, dizziness, confusion, a widespread red rash, nausea, vomiting, and abdominal pain. Other worrisome signs include difficulty breathing, blue lips, extreme drowsiness, or difficulty waking up from sleep.
Prophylaxis, the administration of antibiotics to prevent illness, is a standard treatment. Generally, individuals exposed to someone with a group A strep infection do not require prophylaxis.
Special considerations may lead healthcare providers to suggest prophylaxis for all household members with a confirmed case of invasive group A strep infection, especially if the household includes individuals aged 65 years or older or those at higher risk of developing severe forms of the disease, also, in cases involving exposure to invasive group A strep infections, such as pneumonia, necrotizing fasciitis, or streptococcal toxic shock syndrome.
Considering the escalating numbers, health authorities in Japan are intensifying efforts to find the underlying causes driving this surge in STSS cases. Medical professionals stress the importance of early detection and treatment to mitigate the impact of this deadly bacterial infection.
Stay tuned to reliable health sources and local advisories for further updates and insights into the evolving situation.
References
